Nebius, Stock

Nebius Stock: A 571% Quarter, $325 Million of One-Off Revenue, and the Capacity Handover That Will Settle the Argument

Published on 11/18/2026 at 06:40 | Editorial boerse-global.de
Nebius posted $980.8M Q3 revenue, up 571%, but $325M was non-recurring and capacity delays push some revenue to 2027 as capex rises.
Nebius Stock: A 571% Quarter, $325 Million of One-Off Revenue, and the Capacity Handover That Will Settle the Argument Illustration mit AI erstellt.

Nebius closed the third quarter of 2026 with revenue of $980.8 million, up 571% year on year. Strip out the noise, though, and a more awkward question surfaces: how much of that figure comes back next quarter? Roughly $325 million of the total arrived as non-recurring revenue from the company's capital-light business — a genuine contribution to the reported result, but not a base anyone should extrapolate from without care.

That distinction turns revenue quality into the real test of the investment case. Bulls don't simply need more demand; they need demand that converts into repeatable billings. One-off items can top up a business. They cannot substitute for a durable revenue floor.

Signed contracts are not yet booked revenue

The demand side, at least, looks well supported. Since the start of the third quarter, customers have committed to contracts worth more than $12 billion, according to the company. That is a meaningful endorsement of the franchise — but a contract value is not the same thing as revenue already on the books, and the gap between the two is where the analytical work now sits.

Management gave that gap a name on Thursday, disclosing that capacity delays at third-party providers will push a portion of expected revenue into 2027. The disclosure describes a shift in timing, not a promise that the money arrives later. If the capacity comes online and the revenue follows, the soft patch reads as a scheduling setback. If delays repeat, the credibility of the whole plan deserves a harder look.

For 2026 itself, Nebius guided revenue to the low end of a $3 billion to $3.4 billion range. That sets a clearer bar for the current year, though the more consequential question is whether the company can put the cause of the slip behind it.

Should investors sell immediately? Or is it worth buying Nebius?

The earnings picture cuts two ways

Profitability offers a useful lens on execution. Nebius reported adjusted EBITDA of $465.8 million, yet a net loss of $37.5 million from continuing operations. The spread matters: the adjusted operating figure and the bottom line tell different stories, and a convincing trajectory would require not just additional revenue but visible progress in converting it into sustainable earnings.

Analysts have been recalibrating without abandoning ship. Citi's Tyler Radke cut his price target to $215 from $265 on Monday while keeping a Buy rating. Bank of America's Tal Liani moved to $265 from $310 the same day, also maintaining a Buy and pointing explicitly to capacity delays. D.A. Davidson's Gil Luria took a sharper knife to his target on Friday, halving it to $125 from $250 — though his rating stayed Neutral. The spread between $125 and $265 captures the range of conviction about revenue that has yet to arrive.

Capex raises the stakes on timing

What makes the delay more than a footnote is the spending behind it. Nebius lifted its 2026 capital expenditure forecast on Thursday to roughly $27 billion, and offered a first outlook for next year of $40 billion to $45 billion. At that scale, the calendar matters as much as the demand.

The risk isn't confined to whether customers show up. Even with contracts signed, additional infrastructure has to be ready on schedule; slippage weakens the link between what is spent and what is earned. Higher outlays on their own prove nothing about higher returns — and if rising capex collides with repeated postponements, investors end up paying more for a payoff that keeps receding.

One concrete checkpoint sits on the calendar: the remaining capacity at the New Jersey site earmarked for Microsoft is due to be handed over in the second quarter of 2027. According to media reports, third-party operator DataOne halted temporary power generation ahead of a switch to Bloom Energy fuel cells. The announced date is not a completed buildout, but hitting it would do more to shore up confidence in execution than any single quarter's revenue spike.

What would actually settle it

A constructive case remains available. Limited delays, delivered guidance and the steady conversion of customer commitments into recurring billings would let the one-off contributions read as a supplement to growth rather than a crutch. The operational evidence would then show the buildout stands on solid economic ground, and the discussion could return to expansion rather than slippage.

The bearish reading is just as coherent. If one-time items keep propping up the top line, or if the handover slips again, the signal value of those headline growth rates fades quickly. The next real proof point is delivery against the trimmed full-year revenue target — and beyond that, whether the revenue pushed into 2027 actually lands.

For shareholders, no single analyst's target sets the direction. The decisive evidence will be whether Nebius turns expected future income into reported sales. Until that link is demonstrated, the market has little choice but to keep grading the company on execution rather than on the 571% printed last quarter.

Ad

Nebius Stock: New Analysis - 18 November

Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nebius analysis...

Disclaimer...
en | NL0009805522 | NEBIUS | boerse | 70529614 |